Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
4.100
+0.180 (4.59%)
At close: Nov 22, 2024, 4:00 PM
4.400
+0.300 (7.32%)
After-hours: Nov 22, 2024, 5:37 PM EST
Exagen Market Cap
Exagen has a market cap or net worth of $72.31 million as of November 22, 2024. Its market cap has increased by 145.10% in one year.
Market Cap
72.31M
Enterprise Value
74.02M
1-Year Change
145.10%
Ranking
Category
Stock Price
$4.10
Market Cap Chart
Since September 19, 2019, Exagen's market cap has increased from $63.11M to $72.31M, an increase of 14.59%. That is a compound annual growth rate of 2.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 61.37M | 80.93% |
| Dec 29, 2023 | 33.92M | -13.39% |
| Dec 30, 2022 | 39.17M | -79.17% |
| Dec 31, 2021 | 187.99M | 12.56% |
| Dec 31, 2020 | 167.01M | -47.65% |
| Dec 31, 2019 | 319.05M | 405.58% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Allakos | 73.30M |
| Hyperfine | 72.95M |
| Vivani Medical | 72.94M |
| VolitionRx | 72.80M |
| Rockwell Medical | 72.75M |
| BioAtla | 71.07M |
| electroCore | 70.46M |
| ALX Oncology Holdings | 70.15M |